Klow (70mg)

KLOW is a four-peptide research blend combining GHK-Cu ([X] mg), BPC-157 ([X] mg), TB-500 ([X] mg), and KPV ([X] mg) in a single lyophilized vial.

Each compound in the blend is independently studied: GHK-Cu, a copper-binding tripeptide, is examined in skin remodeling, collagen synthesis, and tissue repair research. BPC-157, a stable gastric pentadecapeptide, appears in studies of tendon, ligament, and gut tissue models. TB-500 (Thymosin Beta-4 fragment) is investigated for cell migration and wound-healing pathways, while KPV, an alpha-MSH fragment, is studied in inflammation models. Combined, KLOW is a popular subject in regenerative and recovery-focused research protocols.

Every batch is third-party tested for purity and identity — lab reports available via the COA page.

For research purposes only. Not for human consumption.